One Man, No Meds — and a Blueprint for a Cure
For more than a decade, the best available HIV drugs couldn't fully control Matt Chappell's infection. Then, in 2014, scientists withdrew his blood, disabled the gene HIV uses to enter T-cells, and reinfused the edited cells. The result was remarkable: Chappell has gone without HIV medication for close to four years — even after cancer treatment temporarily weakened his immune system.
He was the exceptional case. Of roughly 100 participants in Sangamo's early trials, he alone sustained long-term viral control without drugs. For everyone else, standard antiretroviral therapy remained necessary.
How the Editing Works — and Where It Falls Short
The tool at the centre of this research is called zinc finger nucleases — a molecular editor that cuts DNA at precise points to block the gene HIV uses to enter T-cells. It was developed by Sangamo Therapeutics, a California biotech company that sponsored the early studies.
The technique works in principle, but not yet at scale. Dr. Sandy Macrae, Sangamo's president, acknowledged that edited T-cells are still outnumbered by unedited ones — leaving the door open for ongoing infection.
Several researchers are now refining the approach. At the City of Hope research centre in Duarte, California, Dr. John Zaia is editing blood stem cells rather than mature T-cells — reasoning that a corrected stem cell will propagate protection far more broadly and durably. Meanwhile, Dr. Rafick-Pierre Sekaly of Case Western Reserve University is pairing gene editing with at least a year of potent antiviral therapy, aiming to suppress the virus to a level the immune system can then hold on its own — replicating Chappell's outcome deliberately.
Promising, But Not Yet for Everyone
At the UCLA AIDS Institute, Dr. Otto Yang describes gene therapy as entering its most consequential phase. Dr. Anthony Fauci, then director of the National Institute of Allergy and Infectious Diseases, struck a cautiously optimistic note: most people living with HIV manage well on modern regimens, but gene therapy could offer a genuine lifeline for those who don't respond to standard treatment.
"They are very bold and innovative techniques, trying to cure people. It is worth giving a try — the potential is there."
The only confirmed HIV cure to date involved a bone-marrow transplant from a donor naturally resistant to the virus — a procedure too dangerous and impractical for widespread use. Gene editing is the field's most credible path to achieving the same immunity without that risk. Chappell, still monitoring his own health closely, believes that if a true cure emerges, this will be the route it takes.
This article is general information gathered from reputable public sources — not a substitute for advice from a qualified healthcare provider.